In vitro activity of a new oral triazole, BMS-207147 (ER-30346)

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 313-318

  Fung Tomc, Joan C ^a   Huczko, Elizabeth ^a   Minassian, Beatrice ^a   Bonner, Daniel P ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; RAVUCONAZOLE; TRIAZOLE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDIASIS; DRUG POTENCY; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDA; CRYPTOCOCCUS; MICROBIAL SENSITIVITY TESTS; THIAZOLES; TRIAZOLES;

EID: 0031938059     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Denning, D. W., R. M. Tucker, L. H. Hanson, and D. A. Stevens. 1989. Treatment of invasive aspergillosis with itraconazole. Am. J. Med. 86:791-800.
2. Espinel-Ingroff, A., and T. M. Kerkering. 1991. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi. J. Clin. Microbiol. 29:393-394.
3. Fung-Tomc, J. C., U. Minassain, E. Huczko, B. Kolek, D. P. Bonner, and R. E. Kessler. 1995. In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184. Antimicrob. Agents Chemother. 39:295-300.
4. Hata, K., J. Kimura, H. Miki, T. Toyosawa, T. Nakamura, and K. Katsu. 1996. In vitro and in vivo activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents. Chemother. 40:2237-2242.
5. Hata, K., J. Ueno, H. Miki, T. Toyosawa, K. Katsu, T. Nakamura, and T. Horie. 1995. ER-30346, a novel antifungal triazole, III. In vitro activity and its mode of action, abstr. F92, p. 129. In Programs and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. National Committee for Clinical Laboratory Standards. 1996. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. Document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Samaranayake, L. P., and P. Holmstrup. 1989. Oral candidiasis and human immunodeficiency virus infection. J. Oral Pathol. Med. 18:554-564.
8. Viviani, M. A., A. M. Tortorano, M. Langer, M. Almaviva, C. Negri, S. Cristina, S. Scoccia, R. De Maria, R. Fiocchi, P. Ferrazzi, A. Goglio, G. Gavazzeni, G. Faggian, R. Rinaldi, and P. Cadrobbi. 1989. Experience with itraconazole in cryptococcosis and aspergillosis. J. Infect. 18:151-165.